117 related articles for article (PubMed ID: 23058786)
1. The value of C-reactive protein and comorbidity in predicting survival of patients with high grade soft tissue sarcoma.
Nakamura T; Grimer R; Gaston C; Francis M; Charman J; Graunt P; Uchida A; Sudo A; Jeys L
Eur J Cancer; 2013 Jan; 49(2):377-85. PubMed ID: 23058786
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma.
Nakamura T; Matsumine A; Matsubara T; Asanuma K; Uchida A; Sudo A
Cancer; 2012 Feb; 118(4):1055-61. PubMed ID: 21761398
[TBL] [Abstract][Full Text] [Related]
3. The combined use of the neutrophil-lymphocyte ratio and C-reactive protein level as prognostic predictors in adult patients with soft tissue sarcoma.
Nakamura T; Matsumine A; Matsubara T; Asanuma K; Uchida A; Sudo A
J Surg Oncol; 2013 Dec; 108(7):481-5. PubMed ID: 24018883
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of the serum level of C-reactive protein for the survival of patients with a primary sarcoma of bone.
Nakamura T; Grimer RJ; Gaston CL; Watanuki M; Sudo A; Jeys L
Bone Joint J; 2013 Mar; 95-B(3):411-8. PubMed ID: 23450030
[TBL] [Abstract][Full Text] [Related]
5. Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma.
Choi ES; Kim HS; Han I
Ann Surg Oncol; 2014 Mar; 21(3):778-85. PubMed ID: 24306668
[TBL] [Abstract][Full Text] [Related]
6. Role of high-sensitivity C-reactive protein in the differentiation of benign and malignant soft tissue tumors.
Nakamura T; Matsumine A; Iino T; Matsubara T; Asanuma K; Uchida A; Sudo A
Anticancer Res; 2014 Feb; 34(2):933-6. PubMed ID: 24511035
[TBL] [Abstract][Full Text] [Related]
7. The relationship between pretreatment anaemia and survival in patients with adult soft tissue sarcoma.
Nakamura T; Grimer R; Gaston C; Carter S; Tillman R; Abudu A; Jeys L; Sudo A
J Orthop Sci; 2013 Nov; 18(6):987-93. PubMed ID: 23943226
[TBL] [Abstract][Full Text] [Related]
8. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma.
Hashimoto K; Ikeda Y; Korenaga D; Tanoue K; Hamatake M; Kawasaki K; Yamaoka T; Iwatani Y; Akazawa K; Takenaka K
Cancer; 2005 May; 103(9):1856-64. PubMed ID: 15779015
[TBL] [Abstract][Full Text] [Related]
9. The role of C-reactive protein in predicting post-metastatic survival of patients with metastatic bone and soft tissue sarcoma.
Nakamura T; Matsumine A; Asanuma K; Matsubara T; Sudo A
Tumour Biol; 2015 Sep; 36(10):7515-20. PubMed ID: 25913621
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of erythrocyte sedimentation rate, C-reactive protein and serum lactate dehydrogenase levels in the diagnosis, prognosis and treatment monitoring of children suffering from cancer].
Bień E; Balcerska A
Med Wieku Rozwoj; 2004; 8(4 Pt 2):1081-9. PubMed ID: 15951603
[TBL] [Abstract][Full Text] [Related]
11. Clinical implication of pretreatment neutrophil to lymphocyte ratio in soft tissue sarcoma.
Idowu OK; Ding Q; Taktak AF; Chandrasekar CR; Yin Q
Biomarkers; 2012 Sep; 17(6):539-44. PubMed ID: 22793493
[TBL] [Abstract][Full Text] [Related]
12. Serum C-reactive protein levels predict survival in hepatocellular carcinoma.
Nagaoka S; Yoshida T; Akiyoshi J; Akiba J; Torimura T; Adachi H; Kurogi J; Tajiri N; Inoue K; Niizeki T; Koga H; Imaizumi T; Kojiro M; Sata M
Liver Int; 2007 Oct; 27(8):1091-7. PubMed ID: 17845537
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS; Evans HL
Cancer; 2003 May; 97(10):2530-43. PubMed ID: 12733153
[TBL] [Abstract][Full Text] [Related]
14. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
15. Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma.
Saito K; Tatokoro M; Fujii Y; Iimura Y; Koga F; Kawakami S; Kihara K
Eur Urol; 2009 May; 55(5):1145-53. PubMed ID: 18930583
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy.
Bedke J; Chun FK; Merseburger A; Scharpf M; Kasprzyk K; Schilling D; Sievert KD; Stenzl A; Kruck S
BJU Int; 2012 Dec; 110(11 Pt B):E771-7. PubMed ID: 23134582
[TBL] [Abstract][Full Text] [Related]
17. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
Komai Y; Saito K; Sakai K; Morimoto S
BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
[TBL] [Abstract][Full Text] [Related]
18. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy.
Yoshida S; Saito K; Koga F; Yokoyama M; Kageyama Y; Masuda H; Kobayashi T; Kawakami S; Kihara K
BJU Int; 2008 Apr; 101(8):978-81. PubMed ID: 18190628
[TBL] [Abstract][Full Text] [Related]
20. Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score.
Gakis G; Todenhöfer T; Renninger M; Schilling D; Sievert KD; Schwentner C; Stenzl A
BJU Int; 2011 Dec; 108(11):1800-5. PubMed ID: 21507193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
